Ethan Shen PhD - 17 Feb 2026 SCHEDULE 13G/A Report for YD Bio Ltd Ordinary Shares, par value of US$0.0001 per share (YDES)

Filing Manager: Ethan Shen PhD
Reporting Manager: Ethan Shen
Security: YD Bio Ltd Ordinary Shares, par value of US$0.0001 per share
Symbol: YDES
Shares outstanding: 70,522,983 shares
Disclosed Ownership: 54,345,011 shares
Ownership: 77%
Form type: SCHEDULE 13G/A
Filing time: 17 Feb 2026, 21:39:48 UTC
Date of event: 17 Feb 2026
Previous filing: 16 Dec 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Ethan Shen	77%	54,345,011	11,224,153	43,120,858	/s/ Ethan Shen	Ethan Shen
YD Biopharma Holding Limited	61%	43,120,858	0	43,120,858	/s/ Ethan Shen	Director